|
🐬
|
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.
H. Collard,
T. King,
B. B. Bartelson,
J. Vourlekis,
M. Schwarz,
K. Brown
|
9 |
2003 |
9
🐬
|
|
🦁
|
The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis.
8 auth.
J. Vourlekis,
M. Schwarz,
R. Cherniack,
D. Curran-Everett,
C. Cool,
R. Tuder,
...
T. King,
K. Brown
|
7 |
2004 |
7
🦁
|
|
🦁
|
Acute Interstitial Pneumonitis: Case Series and Review of the Literature
7 auth.
J. Vourlekis,
K. Brown,
C. Cool,
D. Young,
R. Cherniack,
T. King,
...
M. Schwarz
|
7 |
2000 |
7
🦁
|
|
🐜
|
Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival.
7 auth.
H. Sahin,
K. Brown,
D. Curran-Everett,
V. Hale,
C. Cool,
J. Vourlekis,
...
D. Lynch
|
6 |
2007 |
6
🐜
|
|
🦁
|
Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis.
J. Vourlekis,
M. Schwarz,
C. Cool,
R. Tuder,
T. King,
K. Brown
|
6 |
2002 |
6
🦁
|
|
🦁
|
Acute interstitial pneumonia.
J. Vourlekis
|
5 |
2004 |
5
🦁
|
|
🦁
|
Acute interstitial pneumonitis: current understanding regarding diagnosis, pathogenesis, and natural history.
J. Vourlekis,
Kevin K. Brown,
Marvin I. Schwarz
|
4 |
2001 |
4
🦁
|
|
🦁
|
Sarcoidosis: developments in etiology, immunology, and therapeutics.
J. Vourlekis,
R. Sawyer,
L. Newman
|
4 |
2000 |
4
🦁
|
|
🐢
|
Submassive pulmonary embolism.
L. Busse,
J. Vourlekis
|
3 |
2014 |
3
🐢
|
|
🦁
|
Predicting success in cancer prevention trials.
J. Vourlekis,
E. Szabo
|
3 |
2003 |
3
🦁
|
